Literature DB >> 1808213

The effects of dimethyl sulfoxide and retinoic acid on the cell growth and the phenotype of ovarian cancer cells.

T W Grunt1, C Somay, M Pavelka, A Ellinger, E Dittrich, C Dittrich.   

Abstract

We have compared the in vitro effects of the differentiation inducers dimethyl sulfoxide (DMSO) and retinoic acid (RA) on a polyclonal human ovarian cancer cell line (HOC-7). Density gradient fractionation of untreated cells reveals that a proportion of rapidly growing, polygonal cells with medium density is capable of spontaneous reversion into a slowly growing low-density phenotype with flattened morphology similar to non-transformed human ovarian surface epithelial cells. Clonal expansion of these low-density cells proves that the observed characteristics are stable for prolonged culture periods. Exposure of HOC-7 cells to DMSO and RA or removal of the serum from the medium is effective in enhancing the proportion of these low-density cells. Application of DMSO causes the cells to become flattened and elongated, and to develop rod-like protrusions. In these cytoplasmic extensions thick filament bundles are dominant. Immunofluorescence studies demonstrate that both untreated low-density subclones and DMSO-treated polyclonal cells are much more reactive for cytokeratin than medium-density subclones or untreated parental cells. Furthermore, immunocytochemistry and fixed-cell ELISA reveal 2- to 5-fold greater amounts of desmoplakins I and II and of fibronectin in low-density subclones and in DMSO-treated cells as compared to medium-density subclones and control cultures. RA exerts weaker effects on the phenotype of the cells. Both inducers reduce DNA synthesis and inhibit the anchorage-dependent and the anchorage-independent cell growth in a dose- and time-dependent manner. The restoration of the original morphology and growth rate after removal of the differentiation-inducing agents proves that the observed changes are reversible; this indicates that the cells do not become terminally differentiated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1808213     DOI: 10.1242/jcs.100.3.657

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  5 in total

1.  Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors.

Authors:  Krishna Penumatsa; Seby L Edassery; Animesh Barua; Michael J Bradaric; Judith L Luborsky
Journal:  J Ovarian Res       Date:  2010-12-22       Impact factor: 4.234

2.  Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells.

Authors:  C Somay; T W Grunt; C Mannhalter; C Dittrich
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

3.  Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene.

Authors:  G Krupitza; R Fritsche; E Dittrich; H Harant; H Huber; T Grunt; C Dittrich
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

4.  Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cells.

Authors:  E Dittrich; M Offterdinger; S M Schneider; Ch Dittrich; H Huber
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

5.  Microenvironmental stiffness enhances glioma cell proliferation by stimulating epidermal growth factor receptor signaling.

Authors:  Vaibhavi Umesh; Andrew D Rape; Theresa A Ulrich; Sanjay Kumar
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.